Filed Pursuant to Rule 433

Dated February 23, 2026

Registration Statement No. 333-293636

FINAL TERM SHEET

Floating Rate Notes due 2029

Issuer:	Abbott Laboratories
Principal Amount:	$1,000,000,000
Interest:	The Floating Rate Notes will bear interest at a floating rate equal to a benchmark rate, which will initially be Compounded SOFR (as defined in the Prospectus Supplement under “Description of Notes”), plus a spread of 0.500% per year, accruing from March 9, 2026.
Maturity:	March 9, 2029
Price to Public:	100.000% plus accrued interest, if any, from March 9, 2026
Interest Rate Basis:	Compounded SOFR
Spread to Compounded SOFR:	+50 bps
Interest Payment Dates:	Each March 9, June 9, September 9 and December 9, commencing June 9, 2026
Interest Payment Determination Date:	The date that is two U.S. Government Securities Business Days before each interest payment date.
Interest Period:	The period from, and including, the most recent interest payment date for the Floating Rate Notes (or, with respect to the initial interest period only, from and including March 9, 2026) to, but excluding, the next succeeding interest payment date for the Floating Rate Notes, or in the case of the last such period, from, and including, the interest payment date for the Floating Rate Notes immediately preceding the maturity date to, but excluding, the maturity date.
Observation Period:	In respect of each interest period, the period from, and including, the date that is two U.S. Government Securities Business Days preceding the first date in such interest period to, but excluding, the Interest Payment Determination Date for such interest period.
Settlement Date:	March 9, 2026
Optional Redemption Provisions:	The Floating Rate Notes are not redeemable prior to maturity, with the exception of a Special Mandatory Redemption.

Special Mandatory Redemption Provisions:	As described in the Preliminary Prospectus Supplement dated February 23, 2026.
CUSIP:	002824 BY5
Joint Bookrunning Managers:	Morgan Stanley & Co. LLC Barclays Capital Inc. BofA Securities, Inc. J.P. Morgan Securities LLC Citigroup Global Markets Inc.
Co-Managers:	BNP Paribas Securities Corp. Deutsche Bank Securities Inc. MUFG Securities Americas Inc. SG Americas Securities, LLC HSBC Securities (USA) Inc. Mizuho Securities USA LLC Santander US Capital Markets LLC Standard Chartered Bank Goldman Sachs & Co. LLC RBC Capital Markets, LLC Siebert Williams Shank & Co., LLC Academy Securities, Inc. BBVA Securities Inc. ING Financial Markets LLC U.S. Bancorp Investments, Inc.
Calculation Agent:	U.S. Bank Trust Company, National Association

The issuer has filed a registration statement (including a prospectus) with the Commission for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the Commission for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the Commission website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Morgan Stanley & Co. LLC, toll-free at (866) 718-1649, Barclays Capital Inc. at (888) 603-5847, BofA Securities, Inc. toll-free at 1-800-294-1322 or J.P. Morgan Securities LLC collect at (212) 834-4533.

The issuer expects to deliver the notes against payment for the notes on or about March 9, 2026, which will be the tenth business day following the date of the pricing of the notes. Under Rule 15c6-1 of the Exchange Act, trades in the secondary market generally are required to settle in one business day, unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade their notes prior to the business day before the delivery of the notes hereunder will be required, by virtue of the fact that the notes initially will settle in T+10, to specify alternative settlement arrangements to prevent a failed settlement.

2

FINAL TERM SHEET

3.700% Notes due 2029

Issuer:	Abbott Laboratories
Principal Amount:	$2,250,000,000
Coupon:	3.700%
Maturity:	March 9, 2029
Price to Public:	99.873% plus accrued interest, if any, from March 9, 2026
Yield to maturity:	3.745%
Benchmark Treasury:	3.500% due February 15, 2029
Spread to Benchmark Treasury:	+30 bps
Treasury Price and Yield:	100-04 7/8 / 3.445%
Coupon Dates:	Semiannually on March 9 and September 9
First Coupon:	September 9, 2026
Settlement Date:	March 9, 2026
Par Call Date:	February 9, 2029
Optional Redemption Provisions:	Abbott may redeem the notes at any time prior to the Par Call Date in whole or in part, in each case at Abbott’s option, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the sum of: the greater of (1) 100% of the principal amount of the notes being redeemed, or (2) the sum of the present values of the remaining scheduled payments (through the Par Call Date assuming for such purpose the notes matured on the Par Call Date) of principal and interest on the notes being redeemed (exclusive of interest accrued to the redemption date), discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at a rate equal to the Treasury Rate plus 5 basis points, plus, in either case, accrued and unpaid interest, if any, to, but excluding, the redemption date on the principal amount of the notes being redeemed. In addition, Abbott may redeem the notes at any time on or after the Par Call Date in whole or in part, in each case at Abbott’s option, at a redemption price equal to 100% of the principal amount of the notes to be redeemed plus accrued and unpaid interest, if any, to, but excluding, the redemption date.

3

Special Mandatory Redemption Provisions:	As described in the Preliminary Prospectus Supplement dated February 23, 2026.
CUSIP:	002824 BR0
Joint Bookrunning Managers:	Morgan Stanley & Co. LLC Barclays Capital Inc. BofA Securities, Inc. J.P. Morgan Securities LLC Citigroup Global Markets Inc.
Co-Managers:	BNP Paribas Securities Corp. Deutsche Bank Securities Inc. MUFG Securities Americas Inc. SG Americas Securities, LLC HSBC Securities (USA) Inc. Mizuho Securities USA LLC Santander US Capital Markets LLC Standard Chartered Bank Goldman Sachs & Co. LLC RBC Capital Markets, LLC Siebert Williams Shank & Co., LLC Academy Securities, Inc. BBVA Securities Inc. ING Financial Markets LLC U.S. Bancorp Investments, Inc.

The issuer has filed a registration statement (including a prospectus) with the Commission for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the Commission for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the Commission website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Morgan Stanley & Co. LLC, toll-free at (866) 718-1649, Barclays Capital Inc. at (888) 603-5847, BofA Securities, Inc. toll-free at 1-800-294-1322 or J.P. Morgan Securities LLC collect at (212) 834-4533.

The issuer expects to deliver the notes against payment for the notes on or about March 9, 2026, which will be the tenth business day following the date of the pricing of the notes. Under Rule 15c6-1 of the Exchange Act, trades in the secondary market generally are required to settle in one business day, unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade their notes prior to the business day before the delivery of the notes hereunder will be required, by virtue of the fact that the notes initially will settle in T+10, to specify alternative settlement arrangements to prevent a failed settlement.

4

FINAL TERM SHEET

4.000% Notes due 2031

Issuer:	Abbott Laboratories
Principal Amount:	$2,500,000,000
Coupon:	4.000%
Maturity:	March 15, 2031
Price to Public:	99.855% plus accrued interest, if any, from March 9, 2026
Yield to maturity:	4.032%
Benchmark Treasury:	3.750% due January 31, 2031
Spread to Benchmark Treasury:	+45 bps
Treasury Price and Yield:	100-24 / 3.582%
Coupon Dates:	Semiannually on March 15 and September 15
First Coupon:	September 15, 2026
Settlement Date:	March 9, 2026
Par Call Date:	February 15, 2031
Optional Redemption Provisions:	Abbott may redeem the notes at any time prior to the Par Call Date in whole or in part, in each case at Abbott’s option, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the sum of: the greater of (1) 100% of the principal amount of the notes being redeemed, or (2) the sum of the present values of the remaining scheduled payments (through the Par Call Date assuming for such purpose the notes matured on the Par Call Date) of principal and interest on the notes being redeemed (exclusive of interest accrued to the redemption date), discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at a rate equal to the Treasury Rate plus 10 basis points, plus, in either case, accrued and unpaid interest, if any, to, but excluding, the redemption date on the principal amount of the notes being redeemed. In addition, Abbott may redeem the notes at any time on or after the Par Call Date in whole or in part, in each case at Abbott’s option, at a redemption price equal to 100% of the principal amount of the notes to be redeemed plus accrued and unpaid interest, if any, to, but excluding, the redemption date.

5

Special Mandatory Redemption Provisions:	As described in the Preliminary Prospectus Supplement dated February 23, 2026.
CUSIP:	002824 BS8
Joint Bookrunning Managers:	Morgan Stanley & Co. LLC Barclays Capital Inc. BofA Securities, Inc. J.P. Morgan Securities LLC BNP Paribas Securities Corp.
Co-Managers:	Citigroup Global Markets Inc. Deutsche Bank Securities Inc. MUFG Securities Americas Inc. SG Americas Securities, LLC HSBC Securities (USA) Inc. Mizuho Securities USA LLC Santander US Capital Markets LLC Standard Chartered Bank Goldman Sachs & Co. LLC RBC Capital Markets, LLC Siebert Williams Shank & Co., LLC Academy Securities, Inc. BBVA Securities Inc. ING Financial Markets LLC U.S. Bancorp Investments, Inc.

The issuer has filed a registration statement (including a prospectus) with the Commission for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the Commission for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the Commission website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Morgan Stanley & Co. LLC, toll-free at (866) 718-1649, Barclays Capital Inc. at (888) 603-5847, BofA Securities, Inc. toll-free at 1-800-294-1322 or J.P. Morgan Securities LLC collect at (212) 834-4533.

The issuer expects to deliver the notes against payment for the notes on or about March 9, 2026, which will be the tenth business day following the date of the pricing of the notes. Under Rule 15c6-1 of the Exchange Act, trades in the secondary market generally are required to settle in one business day, unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade their notes prior to the business day before the delivery of the notes hereunder will be required, by virtue of the fact that the notes initially will settle in T+10, to specify alternative settlement arrangements to prevent a failed settlement.

6

FINAL TERM SHEET

4.300% Notes due 2033

Issuer:	Abbott Laboratories
Principal Amount:	$2,750,000,000
Coupon:	4.300%
Maturity:	March 15, 2033
Price to Public:	99.813% plus accrued interest, if any, from March 9, 2026
Yield to maturity:	4.331%
Benchmark Treasury:	4.000% due January 31, 2033
Spread to Benchmark Treasury:	+55 bps
Treasury Price and Yield:	101-10 1/4 / 3.781%
Coupon Dates:	Semiannually on March 15 and September 15
First Coupon:	September 15, 2026
Settlement Date:	March 9, 2026
Par Call Date:	January 15, 2033
Optional Redemption Provisions:	Abbott may redeem the notes at any time prior to the Par Call Date in whole or in part, in each case at Abbott’s option, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the sum of: the greater of (1) 100% of the principal amount of the notes being redeemed, or (2) the sum of the present values of the remaining scheduled payments (through the Par Call Date assuming for such purpose the notes matured on the Par Call Date) of principal and interest on the notes being redeemed (exclusive of interest accrued to the redemption date), discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at a rate equal to the Treasury Rate plus 10 basis points, plus, in either case, accrued and unpaid interest, if any, to, but excluding, the redemption date on the principal amount of the notes being redeemed. In addition, Abbott may redeem the notes at any time on or after the Par Call Date in whole or in part, in each case at Abbott’s option, at a redemption price equal to 100% of the principal amount of the notes to be redeemed plus accrued and unpaid interest, if any, to, but excluding, the redemption date.

7

Special Mandatory Redemption Provisions:	As described in the Preliminary Prospectus Supplement dated February 23, 2026.
CUSIP:	002824 BT6
Joint Bookrunning Managers:	Morgan Stanley & Co. LLC Barclays Capital Inc. BofA Securities, Inc. J.P. Morgan Securities LLC MUFG Securities Americas Inc.
Co-Managers:	BNP Paribas Securities Corp. Citigroup Global Markets Inc. Deutsche Bank Securities Inc. SG Americas Securities, LLC HSBC Securities (USA) Inc. Mizuho Securities USA LLC Santander US Capital Markets LLC Standard Chartered Bank Goldman Sachs & Co. LLC RBC Capital Markets, LLC Siebert Williams Shank & Co., LLC Academy Securities, Inc. BBVA Securities Inc. ING Financial Markets LLC U.S. Bancorp Investments, Inc.

The issuer has filed a registration statement (including a prospectus) with the Commission for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the Commission for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the Commission website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Morgan Stanley & Co. LLC, toll-free at (866) 718-1649, Barclays Capital Inc. at (888) 603-5847, BofA Securities, Inc. toll-free at 1-800-294-1322 or J.P. Morgan Securities LLC collect at (212) 834-4533.

The issuer expects to deliver the notes against payment for the notes on or about March 9, 2026, which will be the tenth business day following the date of the pricing of the notes. Under Rule 15c6-1 of the Exchange Act, trades in the secondary market generally are required to settle in one business day, unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade their notes prior to the business day before the delivery of the notes hereunder will be required, by virtue of the fact that the notes initially will settle in T+10, to specify alternative settlement arrangements to prevent a failed settlement.

8

FINAL TERM SHEET

4.650% Notes due 2036

Issuer:	Abbott Laboratories
Principal Amount:	$3,750,000,000
Coupon:	4.650%
Maturity:	March 15, 2036
Price to Public:	99.753% plus accrued interest, if any, from March 9, 2026
Yield to maturity:	4.681%
Benchmark Treasury:	4.125% due February 15, 2036
Spread to Benchmark Treasury:	+65 bps
Treasury Price and Yield:	100-24 + / 4.031%
Coupon Dates:	Semiannually on March 15 and September 15
First Coupon:	September 15, 2026
Settlement Date:	March 9, 2026
Par Call Date:	December 15, 2035
Optional Redemption Provisions:	Abbott may redeem the notes at any time prior to the Par Call Date in whole or in part, in each case at Abbott’s option, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the sum of: the greater of (1) 100% of the principal amount of the notes being redeemed, or (2) the sum of the present values of the remaining scheduled payments (through the Par Call Date assuming for such purpose the notes matured on the Par Call Date) of principal and interest on the notes being redeemed (exclusive of interest accrued to the redemption date), discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at a rate equal to the Treasury Rate plus 10 basis points, plus, in either case, accrued and unpaid interest, if any, to, but excluding, the redemption date on the principal amount of the notes being redeemed. In addition, Abbott may redeem the notes at any time on or after the Par Call Date in whole or in part, in each case at Abbott’s option, at a redemption price equal to 100% of the principal amount of the notes to be redeemed plus accrued and unpaid interest, if any, to, but excluding, the redemption date.

9

Special Mandatory Redemption Provisions:	As described in the Preliminary Prospectus Supplement dated February 23, 2026.
CUSIP:	002824 BU3
Joint Bookrunning Managers:	Morgan Stanley & Co. LLC Barclays Capital Inc. BofA Securities, Inc. J.P. Morgan Securities LLC SG Americas Securities, LLC
Co-Managers:	BNP Paribas Securities Corp. Citigroup Global Markets Inc. Deutsche Bank Securities Inc. MUFG Securities Americas Inc. HSBC Securities (USA) Inc. Mizuho Securities USA LLC Santander US Capital Markets LLC Standard Chartered Bank Goldman Sachs & Co. LLC RBC Capital Markets, LLC Siebert Williams Shank & Co., LLC Academy Securities, Inc. BBVA Securities Inc. ING Financial Markets LLC U.S. Bancorp Investments, Inc.

The issuer has filed a registration statement (including a prospectus) with the Commission for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the Commission for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the Commission website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Morgan Stanley & Co. LLC, toll-free at (866) 718-1649, Barclays Capital Inc. at (888) 603-5847, BofA Securities, Inc. toll-free at 1-800-294-1322 or J.P. Morgan Securities LLC collect at (212) 834-4533.

The issuer expects to deliver the notes against payment for the notes on or about March 9, 2026, which will be the tenth business day following the date of the pricing of the notes. Under Rule 15c6-1 of the Exchange Act, trades in the secondary market generally are required to settle in one business day, unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade their notes prior to the business day before the delivery of the notes hereunder will be required, by virtue of the fact that the notes initially will settle in T+10, to specify alternative settlement arrangements to prevent a failed settlement.

10

FINAL TERM SHEET

4.750% Notes due 2038

Issuer:	Abbott Laboratories
Principal Amount:	$2,000,000,000
Coupon:	4.750%
Maturity:	March 15, 2038
Price to Public:	99.718% plus accrued interest, if any, from March 9, 2026
Yield to maturity:	4.781%
Benchmark Treasury:	4.125% due February 15, 2036
Spread to Benchmark Treasury:	+75 bps
Treasury Price and Yield:	100-24 + / 4.031%
Coupon Dates:	Semiannually on March 15 and September 15
First Coupon:	September 15, 2026
Settlement Date:	March 9, 2026
Par Call Date:	December 15, 2037
Optional Redemption Provisions:	Abbott may redeem the notes at any time prior to the Par Call Date in whole or in part, in each case at Abbott’s option, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the sum of: the greater of (1) 100% of the principal amount of the notes being redeemed, or (2) the sum of the present values of the remaining scheduled payments (through the Par Call Date assuming for such purpose the notes matured on the Par Call Date) of principal and interest on the notes being redeemed (exclusive of interest accrued to the redemption date), discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at a rate equal to the Treasury Rate plus 15 basis points, plus, in either case, accrued and unpaid interest, if any, to, but excluding, the redemption date on the principal amount of the notes being redeemed. In addition, Abbott may redeem the notes at any time on or after the Par Call Date in whole or in part, in each case at Abbott’s option, at a redemption price equal to 100% of the principal amount of the notes to be redeemed plus accrued and unpaid interest, if any, to, but excluding, the redemption date.

11

Special Mandatory Redemption Provisions:	As described in the Preliminary Prospectus Supplement dated February 23, 2026.
CUSIP:	002824 BV1
Joint Bookrunning Managers:	Morgan Stanley & Co. LLC Barclays Capital Inc. BofA Securities, Inc. J.P. Morgan Securities LLC BNP Paribas Securities Corp.
Co-Managers:	Citigroup Global Markets Inc. Deutsche Bank Securities Inc. MUFG Securities Americas Inc. SG Americas Securities, LLC HSBC Securities (USA) Inc. Mizuho Securities USA LLC Santander US Capital Markets LLC Standard Chartered Bank Goldman Sachs & Co. LLC RBC Capital Markets, LLC Siebert Williams Shank & Co., LLC Academy Securities, Inc. BBVA Securities Inc. ING Financial Markets LLC U.S. Bancorp Investments, Inc.

The issuer has filed a registration statement (including a prospectus) with the Commission for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the Commission for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the Commission website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Morgan Stanley & Co. LLC, toll-free at (866) 718-1649, Barclays Capital Inc. at (888) 603-5847, BofA Securities, Inc. toll-free at 1-800-294-1322 or J.P. Morgan Securities LLC collect at (212) 834-4533.

The issuer expects to deliver the notes against payment for the notes on or about March 9, 2026, which will be the tenth business day following the date of the pricing of the notes. Under Rule 15c6-1 of the Exchange Act, trades in the secondary market generally are required to settle in one business day, unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade their notes prior to the business day before the delivery of the notes hereunder will be required, by virtue of the fact that the notes initially will settle in T+10, to specify alternative settlement arrangements to prevent a failed settlement.

12

FINAL TERM SHEET

5.500% Notes due 2056

Issuer:	Abbott Laboratories
Principal Amount:	$3,750,000,000
Coupon:	5.500%
Maturity:	March 15, 2056
Price to Public:	99.882% plus accrued interest, if any, from March 9, 2026
Yield to maturity:	5.508%
Benchmark Treasury:	4.625% due November 15, 2055
Spread to Benchmark Treasury:	+80 bps
Treasury Price and Yield:	98-21 + / 4.708%
Coupon Dates:	Semiannually on March 15 and September 15
First Coupon:	September 15, 2026
Settlement Date:	March 9, 2026
Par Call Date:	September 15, 2055
Optional Redemption Provisions:	Abbott may redeem the notes at any time prior to the Par Call Date in whole or in part, in each case at Abbott’s option, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the sum of: the greater of (1) 100% of the principal amount of the notes being redeemed, or (2) the sum of the present values of the remaining scheduled payments (through the Par Call Date assuming for such purpose the notes matured on the Par Call Date) of principal and interest on the notes being redeemed (exclusive of interest accrued to the redemption date), discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at a rate equal to the Treasury Rate plus 15 basis points, plus, in either case, accrued and unpaid interest, if any, to, but excluding, the redemption date on the principal amount of the notes being redeemed. In addition, Abbott may redeem the notes at any time on or after the Par Call Date in whole or in part, in each case at Abbott’s option, at a redemption price equal to 100% of the principal amount of the notes to be redeemed plus accrued and unpaid interest, if any, to, but excluding, the redemption date.

13

Special Mandatory Redemption Provisions:	As described in the Preliminary Prospectus Supplement dated February 23, 2026.
CUSIP:	002824 BW9
Joint Bookrunning Managers:	Morgan Stanley & Co. LLC Barclays Capital Inc. BofA Securities, Inc. J.P. Morgan Securities LLC Deutsche Bank Securities Inc.
Co-Managers:	BNP Paribas Securities Corp. Citigroup Global Markets Inc. MUFG Securities Americas Inc. SG Americas Securities, LLC HSBC Securities (USA) Inc. Mizuho Securities USA LLC Santander US Capital Markets LLC Standard Chartered Bank Goldman Sachs & Co. LLC RBC Capital Markets, LLC Siebert Williams Shank & Co., LLC Academy Securities, Inc. BBVA Securities Inc. ING Financial Markets LLC U.S. Bancorp Investments, Inc.

The issuer has filed a registration statement (including a prospectus) with the Commission for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the Commission for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the Commission website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Morgan Stanley & Co. LLC, toll-free at (866) 718-1649, Barclays Capital Inc. at (888) 603-5847, BofA Securities, Inc. toll-free at 1-800-294-1322 or J.P. Morgan Securities LLC collect at (212) 834-4533.

The issuer expects to deliver the notes against payment for the notes on or about March 9, 2026, which will be the tenth business day following the date of the pricing of the notes. Under Rule 15c6-1 of the Exchange Act, trades in the secondary market generally are required to settle in one business day, unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade their notes prior to the business day before the delivery of the notes hereunder will be required, by virtue of the fact that the notes initially will settle in T+10, to specify alternative settlement arrangements to prevent a failed settlement.

14

FINAL TERM SHEET

5.600% Notes due 2066

Issuer:	Abbott Laboratories
Principal Amount:	$2,000,000,000
Coupon:	5.600%
Maturity:	March 15, 2066
Price to Public:	99.872% plus accrued interest, if any, from March 9, 2026
Yield to maturity:	5.608%
Benchmark Treasury:	4.625% due November 15, 2055
Spread to Benchmark Treasury:	+90 bps
Treasury Price and Yield:	98-21 + / 4.708%
Coupon Dates:	Semiannually on March 15 and September 15
First Coupon:	September 15, 2026
Settlement Date:	March 9, 2026
Par Call Date:	September 15, 2065
Optional Redemption Provisions:	Abbott may redeem the notes at any time prior to the Par Call Date in whole or in part, in each case at Abbott’s option, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the sum of: the greater of (1) 100% of the principal amount of the notes being redeemed, or (2) the sum of the present values of the remaining scheduled payments (through the Par Call Date assuming for such purpose the notes matured on the Par Call Date) of principal and interest on the notes being redeemed (exclusive of interest accrued to the redemption date), discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at a rate equal to the Treasury Rate plus 15 basis points, plus, in either case, accrued and unpaid interest, if any, to, but excluding, the redemption date on the principal amount of the notes being redeemed. In addition, Abbott may redeem the notes at any time on or after the Par Call Date in whole or in part, in each case at Abbott’s option, at a redemption price equal to 100% of the principal amount of the notes to be redeemed plus accrued and unpaid interest, if any, to, but excluding, the redemption date.

15

Special Mandatory Redemption Provisions:	As described in the Preliminary Prospectus Supplement dated February 23, 2026.
CUSIP:	002824 BX7
Joint Bookrunning Managers:	Morgan Stanley & Co. LLC Barclays Capital Inc. BofA Securities, Inc. J.P. Morgan Securities LLC Citigroup Global Markets Inc.
Co-Managers:	BNP Paribas Securities Corp. Deutsche Bank Securities Inc. MUFG Securities Americas Inc. SG Americas Securities, LLC HSBC Securities (USA) Inc. Mizuho Securities USA LLC Santander US Capital Markets LLC Standard Chartered Bank Goldman Sachs & Co. LLC RBC Capital Markets, LLC Siebert Williams Shank & Co., LLC Academy Securities, Inc. BBVA Securities Inc. ING Financial Markets LLC U.S. Bancorp Investments, Inc.

The issuer has filed a registration statement (including a prospectus) with the Commission for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the Commission for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the Commission website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Morgan Stanley & Co. LLC, toll-free at (866) 718-1649, Barclays Capital Inc. at (888) 603-5847, BofA Securities, Inc. toll-free at 1-800-294-1322 or J.P. Morgan Securities LLC collect at (212) 834-4533.

The issuer expects to deliver the notes against payment for the notes on or about March 9, 2026, which will be the tenth business day following the date of the pricing of the notes. Under Rule 15c6-1 of the Exchange Act, trades in the secondary market generally are required to settle in one business day, unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade their notes prior to the business day before the delivery of the notes hereunder will be required, by virtue of the fact that the notes initially will settle in T+10, to specify alternative settlement arrangements to prevent a failed settlement.

16